Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.
Clinical trial NCT04346199 · COMPLETED
Trial details
- NCT number
- NCT04346199
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-12
- Primary completion
- 2020-11-17
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.